Article Details
Retrieved on: 2021-06-14 11:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... its Phase I/II LCA1 clinical trial and continues to advance two preclinical programs leveraging its AAV technology platform,” said Dr. Fujita. “Together ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here